DashboardPortfoliosWatchlistCommunityDiscoverScreener
Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
  • United States
  • Australia
  • United Kingdom
  • Canada
  • India
  • China
  • Argentina
  • Austria
  • Bahrain
  • Bangladesh
  • Belgium
  • Bermuda
  • Botswana
  • Brazil
  • Bulgaria
  • Chile
  • Colombia
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Egypt
  • Estonia
  • Finland
  • France
  • Germany
  • Ghana
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kenya
  • Kuwait
  • Latvia
  • Lithuania
  • Luxembourg
  • Malawi
  • Malaysia
  • Malta
  • Mauritius
  • Mexico
  • Morocco
  • Namibia
  • Netherlands
  • New Zealand
  • Nigeria
  • Norway
  • Oman
  • Pakistan
  • Palestinian Authority
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Qatar
  • Romania
  • Russia
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Sri Lanka
  • Sweden
  • Switzerland
  • Taiwan
  • Tanzania
  • Thailand
  • Trinidad & Tobago
  • Tunisia
  • Turkey
  • Uganda
  • Ukraine
  • United Arab Emirates
  • Venezuela
  • Vietnam
  • Zambia
  • Zimbabwe
  • All Industries
  • Energy
  • Oil and Gas
  • Oil and Gas Exploration and Production
  • Real Estate
  • Materials
  • Chemicals
  • Commodity Chemicals
  • Specialty Chemicals
  • Metals and Mining
  • Steel
  • Industrials
  • Aerospace & Defense
  • Aerospace and Defense
  • Building
  • Building Products
  • Construction
  • Construction and Engineering
  • Electrical
  • Electrical Components
  • Heavy Electrical Equipment
  • Industrials
  • Industrial Conglomerates
  • Machinery
  • Construction Machinery and Vehicles
  • Industrial Machinery
  • Trade Distributors
  • Trade Companies and Distributors
  • Commercial Services
  • Diversified Support Services
  • Environmental and Facilities Services
  • Office Services and Supplies
  • Professional Services
  • Research and Consulting Services
  • Marine and Shipping
  • Marine
  • Consumer Discretionary
  • Auto Components
  • Auto Parts and Equipment
  • Auto
  • Automobile Manufacturers
  • Consumer Durables
  • Leisure
  • Leisure Products
  • Luxury
  • Apparel, Accessories and Luxury Goods
  • Textiles
  • Hospitality
  • Hotels, Resorts and Cruise Lines
  • Leisure Facilities
  • Specialty Stores
  • Specialty Stores
  • Consumer Staples
  • Food and Staples Retail
  • Beverage
  • Food
  • Packaged Foods and Meats
  • Healthcare
  • Medical Equipment
  • Medical Equipment
  • Healthcare Services
  • Healthcare Distributors
  • Healthcare Facilities
  • Healthtech
  • Healthtech
  • Biotech
  • Biotech
  • Pharma
  • Pharma
  • Life Sciences
  • Clinical Research and Equipment
  • Financials
  • Diversified Financial
  • Specialized Finance
  • Capital Markets
  • Asset Management
  • Investment Banking and Brokerage
  • Insurance
  • General Insurance
  • Tech
  • IT
  • IT Consulting
  • Software
  • Application Software
  • Communications
  • Communications Equipment
  • Tech Hardware
  • Tech Hardware Storage and Peripherals
  • Electronic Equipment and Components
  • Electronic Equipment and Instruments
  • Semiconductors
  • Semiconductor Equipment
  • Semiconductors
  • Telecom
  • Entertainment
  • Movies and Entertainment
  • Interactive Media and Services
  • Interactive Media and Services
  • Media
  • Advertising
  • Publishing
  • Telecom Services and Carriers
  • Integrated Telecom Services
  • Utilities
  • Renewable Energy
Header cover image
  • DE Market
  • /
  • Materials
  • /
  • Chemicals

German (DAX) Specialty Chemicals Industry Analysis

UpdatedSep 13, 2026
DataAggregated Company Financials
Companies10
  • 7D-2.5%
  • 3M3.1%
  • 1Y10.4%
  • YTDn/a

Over the last 7 days, the Specialty Chemicals industry has dropped 2.5%, driven by Symrise declining 3.5%. This takes the industry's 12 month performance to a gain of 10%. As for the next few years, earnings are expected to grow by 32% per annum.

Industry Valuation and Performance

Has the German Specialty Chemicals Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 13 Sep 2026€39.5b€40.0b-€285,486,982.0036.2x-138.3x1x
Tue, 11 Aug 2026€40.4b€39.9b-€310,748,982.0023.5x-130x1x
Thu, 09 Jul 2026€38.8b€39.5b-€976,446,982.0025.6x-39.8x1x
Sat, 06 Jun 2026€37.5b€39.5b-€976,446,982.0026.3x-38.4x0.9x
Mon, 04 May 2026€38.0b€40.0b-€899,270,306.0026.5x-42.3x1x
Wed, 01 Apr 2026€36.1b€40.0b-€851,971,306.0028.3x-42.4x0.9x
Fri, 27 Feb 2026€35.3b€40.2b€615.8m21x57.4x0.9x
Sun, 25 Jan 2026€33.5b€40.8b€260.7m25.5x128.6x0.8x
Tue, 23 Dec 2025€32.5b€40.8b€260.7m23.3x124.7x0.8x
Thu, 20 Nov 2025€32.8b€40.9b€261.0m22.1x125.7x0.8x
Sat, 18 Oct 2025€34.9b€41.8b€784.3m22x44.4x0.8x
Mon, 15 Sep 2025€35.0b€41.8b€784.0m22.1x44.6x0.8x
Wed, 13 Aug 2025€35.6b€41.9b€784.4m18.3x45.4x0.9x
Fri, 11 Jul 2025€38.3b€42.7b€670.0m18.7x57.2x0.9x
Sun, 08 Jun 2025€39.8b€42.7b€670.0m16.8x59.4x0.9x
Tue, 06 May 2025€40.3b€42.7b€719.3m17.3x56x0.9x
Thu, 03 Apr 2025€39.1b€42.7b€763.9m18.2x51.2x0.9x
Sat, 01 Mar 2025€38.5b€42.6b€558.9m25.3x68.9x0.9x
Mon, 27 Jan 2025€37.3b€42.6b€565.2m25.4x66x0.9x
Wed, 25 Dec 2024€37.4b€42.6b€567.6m22.1x65.9x0.9x
Fri, 22 Nov 2024€45.7b€49.4b€489.9m13.3x93.2x0.9x
Sun, 20 Oct 2024€50.5b€49.4b€206.3m14.5x245x1x
Tue, 17 Sep 2024€41.7b€42.6b€184.3m12.5x226.2x1x
Thu, 15 Aug 2024€39.5b€42.6b€185.7m11.2x212.6x0.9x
Sat, 13 Jul 2024€41.6b€42.7b€67.7m13.2x614x1x
Mon, 10 Jun 2024€39.2b€42.7b€67.7m13x578.4x0.9x
Wed, 08 May 2024€39.5b€42.9b-€46,497,601.1014.4x-849.9x0.9x
Fri, 05 Apr 2024€40.6b€43.4b€61.4m14.5x661.7x0.9x
Sun, 03 Mar 2024€37.1b€44.7b€21.1m10.4x1755.5x0.8x
Tue, 30 Jan 2024€36.8b€45.3b-€690,758,524.0011.2x-53.3x0.8x
Thu, 28 Dec 2023€39.0b€45.3b-€689,138,524.0011.8x-56.7x0.9x
Sat, 25 Nov 2023€38.3b€45.3b-€689,138,524.0011.3x-55.6x0.8x
Mon, 23 Oct 2023€35.9b€48.2b-€103,590,524.008.4x-346.4x0.7x
Wed, 20 Sep 2023€38.1b€48.2b-€103,590,524.009.6x-367.6x0.8x
  • Price to Earnings
  • Price to Sales
  • Median Price to Earnings
Price to Earnings Ratio

-367.6x


Wed, 20 Sep 2023
Total Market Cap: €38.1bTotal Earnings: -€103,590,524.00Total Revenue: €48.2bTotal Market Cap vs Earnings and Revenue0%0%0%
German Specialty Chemicals Industry Price to Earnings3Y Average 59x202420252026
Current Industry PE
  • Investors are optimistic on the German Specialty Chemicals industry, and appear confident in long term growth rates.
  • The industry is trading close to its 3-year average PS ratio of 0.90x.
Past Earnings Growth
  • The earnings for companies in the Specialty Chemicals industry have deteriorated over the last three years.
  • Revenues have also declined 6.0% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Comparison

How does German Specialty Chemicals compare with similar industries?

DE Market-1.78%
Materials-3.23%
Chemicals-2.65%
Specialty Chemicals-2.48%
Commodity Chemicals-1.39%
Fertilizers and Agricultural Chemicals-1.43%
Diversified Chemicals-3.02%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1COV Covestro€60.000.2%
+€20.8m
3.0%PS1x
UZU Uzin Utz€70.002.0%
+€7.1m
-5.4%PE13.1x
BNN BRAIN Biotech€2.798.6%
+€4.8m
24.6%PS1.3x
2HRA H&R GmbH KGaA€7.161.1%
+€3.0m
45.2%PE104.8x

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide

Latest News

EVK
€17.86
Evonik Industries
7D
-4.0%
1Y
12.3%
User avatar
Narrative Update • Sep 03

EVK: Execution On New Capacity Investments Is Expected To Support Re Rating

Analysts raised their fair value estimate for Evonik Industries to €22 from €21, citing recent price target increases from several banks and updated assumptions around revenue growth, profit margins and future P/E multiples. Analyst Commentary on Evonik Industries Recent research on Evonik Industries points to a more constructive tone, with several bullish analysts lifting their fair value assumptions and price targets.
SY1
€87.20
Symrise
7D
-3.5%
1Y
8.6%
User avatar
Narrative Update • Sep 03

SY1: Pet Segment Momentum And Pricing Power Shifts Will Shape Future Repricing

Analysts have raised the Symrise fair value estimate from €95.39 to €98.63, citing higher price targets, including Jefferies' increase to €110, and supportive sector views that emphasize improving growth assumptions, particularly in pet-related activities, despite mixed rating actions across the coverage. Analyst Commentary Recent research on Symrise shows a split between bullish analysts who see upside in specific growth drivers and more cautious views that focus on sector risks and execution against current expectations.
WCH
€87.75
Wacker Chemie
7D
-4.9%
1Y
40.1%
User avatar
Narrative Update • Sep 03

WCH: Semi Cycle Caution And Margin Outlook Will Shape Fair Value

Analysts have trimmed their fair value estimate for Wacker Chemie to €104 from €110, reflecting a lower Street price target, now at €85, that is linked to concerns that recent share gains may already factor in much of the expected benefit from the semiconductor cycle. Analyst Commentary Recent Street research on Wacker Chemie has leaned cautious, with price targets centred around €85 and commentary that recent share gains may already reflect a large part of the expected benefit from the semiconductor cycle.
BNN
€2.79
BRAIN Biotech
7D
8.6%
1Y
24.6%
NTG
€12.00
Nabaltec
7D
-4.0%
1Y
-6.6%
Analysis Article • Aug 23

Analysts Have Been Trimming Their Nabaltec AG (ETR:NTG) Price Target After Its Latest Report

Shareholders might have noticed that Nabaltec AG ( ETR:NTG ) filed its interim result this time last week. The early...
UZU
€70.00
Uzin Utz
7D
2.0%
1Y
-5.4%
2HRA
€7.16
H&R GmbH KGaA
7D
1.1%
1Y
45.2%
1COV
€60.00
Covestro
7D
0.2%
1Y
3.0%
ACT
€160.40
AlzChem Group
7D
-1.7%
1Y
13.1%
BIG
€2.62
Bio-Gate
7D
-2.2%
1Y
-41.8%